Mark Hillman

Net buying

Hillman Capital Management, Inc. — managed by Mark Hillman; US equity positions disclosed quarterly via SEC 13F

Data as of 2026-03-31 (filed 2026-05-15) · Source: SEC EDGAR

Portfolio value$144.0M (−9%)

Holdings56

Top holdingBiogen Inc

Below band3

New

Added

Exited

13F × valuation

Valuation posture

Of 14 valued US positions, 3 trade below a conservative value band (as of 2026-07-21):

Adobe IncADBE37% · below
IntuitINTU34% · below
Fiserv IncFISV25% · below

SEC 13F · latest filing

Holdings

Security	Value	Valuation	Holders	Shares	Weight	Signal
Biogen IncBIIB	$5.4M	—	3	29,540	3.8%	Core 8q
Dupont De Nemours IncDD	$5.4M	—	3	117,901	3.7%	Core 8q
Warner Bros Discovery IncWBD	$5.4M	—	5	196,309	3.7%	Core 8q
Gsk PlcGSK	$5.4M	—	8	97,432	3.7%	Core 8q
International Flavors&FragraIFF	$5.3M	—	5	72,773	3.7%	Core 8q
Pfizer IncPFE	$5.3M	—	9	187,937	3.7%	Big new
Zimmer Biomet Holdings IncZBH	$5.0M	—	8	55,700	3.5%	Big new
Cvs Health CorpCVS	$4.8M	—	15	67,462	3.4%	—
Brown Forman CorpBF.B	$4.7M	—	6	176,437	3.2%	Big new
Carmax IncKMX	$4.5M	—	6	109,181	3.2%	—
Kraft Heinz CoKHC	$4.5M	—	9	201,140	3.1%	Big new
Fiserv IncFISV	$4.5M	Below value	10	80,728	3.1%	Adding 3q
Boeing CoBA	$4.4M	—	6	22,326	3.1%	—
Baxter Intl IncBAX	$4.2M	—	8	247,320	2.9%	—
Nike IncNKE	$4.1M	—	8	77,906	2.9%	—
Microsoft CorpMSFT	$4.0M	—	45	10,828	2.8%	—
Adobe IncADBE	$3.9M	Below value	13	16,200	2.7%	—
Lauder Estee Cos IncEL	$3.7M	—	4	52,172	2.6%	—
The Campbells CompanyCPB	$3.7M	—	2	166,178	2.6%	—
Verizon Communications IncVZ	$3.3M	—	9	64,998	2.3%	—
Bristol-Myers Squibb CoBMY	$3.2M	—	10	53,102	2.2%	—
Ishares TrEFA	$3.0M	—	4	30,854	2.1%	Adding 4q
Constellation Brands IncSTZ	$2.8M	—	10	18,795	2.0%	—
Comcast CorpCMCSA	$2.7M	—	16	95,228	1.9%	—
Us BancorpUSB	$2.7M	—	9	52,528	1.9%	—

Biogen IncBIIBCore 8q
Value$5.4MValuation—Holders3Weight3.8%
Dupont De Nemours IncDDCore 8q
Value$5.4MValuation—Holders3Weight3.7%
Warner Bros Discovery IncWBDCore 8q
Value$5.4MValuation—Holders5Weight3.7%
Gsk PlcGSKCore 8q
Value$5.4MValuation—Holders8Weight3.7%
International Flavors&FragraIFFCore 8q
Value$5.3MValuation—Holders5Weight3.7%
Pfizer IncPFEBig new
Value$5.3MValuation—Holders9Weight3.7%
Zimmer Biomet Holdings IncZBHBig new
Value$5.0MValuation—Holders8Weight3.5%
Cvs Health CorpCVS—
Value$4.8MValuation—Holders15Weight3.4%
Brown Forman CorpBF.BBig new
Value$4.7MValuation—Holders6Weight3.2%
Carmax IncKMX—
Value$4.5MValuation—Holders6Weight3.2%
Kraft Heinz CoKHCBig new
Value$4.5MValuation—Holders9Weight3.1%
Fiserv IncFISVAdding 3q
Value$4.5MValuationBelow valueHolders10Weight3.1%
Boeing CoBA—
Value$4.4MValuation—Holders6Weight3.1%
Baxter Intl IncBAX—
Value$4.2MValuation—Holders8Weight2.9%
Nike IncNKE—
Value$4.1MValuation—Holders8Weight2.9%
Microsoft CorpMSFT—
Value$4.0MValuation—Holders45Weight2.8%
Adobe IncADBE—
Value$3.9MValuationBelow valueHolders13Weight2.7%
Lauder Estee Cos IncEL—
Value$3.7MValuation—Holders4Weight2.6%
The Campbells CompanyCPB—
Value$3.7MValuation—Holders2Weight2.6%
Verizon Communications IncVZ—
Value$3.3MValuation—Holders9Weight2.3%
Bristol-Myers Squibb CoBMY—
Value$3.2MValuation—Holders10Weight2.2%
Ishares TrEFAAdding 4q
Value$3.0MValuation—Holders4Weight2.1%
Constellation Brands IncSTZ—
Value$2.8MValuation—Holders10Weight2.0%
Comcast CorpCMCSA—
Value$2.7MValuation—Holders16Weight1.9%
Us BancorpUSB—
Value$2.7MValuation—Holders9Weight1.9%

Showing top 25 of 56 positions

Exited this quarter (6)Asml Holding N V、Anheuser Busch Inbev Sa/Nv、Spdr S&P 500 Etf Tr、Nucor Corp、Microchip Technology Inc、Exxon Mobil Corp

What is a superinvestor

About this investor

Portfolio overview

Hillman Capital Management, Inc.'s most recent 13F filing, for the quarter ended 2026-03-31, reports 56 positions worth $144.0M. The top 5 holdings represent 19% of that value, a broadly diversified portfolio.

The single largest position is Biogen Inc at 3.8% of the portfolio, followed by Dupont De Nemours Inc at 3.7% and Warner Bros Discovery Inc at 3.7%.

Against the prior quarter, Mark Hillman opened 6 new positions, exited 6, added to 25, and trimmed 23. The largest new buy was Oracle Corp. The most notable sale was the full exit from Anheuser Busch Inbev Sa/Nv.

Across all 8 quarters on file, Biogen Inc has appeared in every filing, as has Dupont De Nemours Inc. Biogen Inc currently ranks first by value.

A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.

Mark Hillman has no positions in the strike zone right now. Browse the whole market by value band

Sources· SEC EDGAR 13F as of 2026-03-31 · filed 2026-05-15

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.